Novo Nordisk's plan to gain ground in the GLP-1 space is slowly taking shape.

A Novo executive noted that many customers are unaware that the company already makes oral semaglutide for type 2 diabetes ...

Feb 4 (Reuters) - Novo Nordisk said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said ...

Novo Nordisk today announced the launch of a new consumer campaign for Ozempic (R) (semaglutide) injection 0.5 mg, 1 mg, and 2 mg, reinventing how traditional pharma advertising is being done. The ...

The company is banking on its Wegovy pill and next-generation weight loss injectable CagriSema to recapture share of the key U.S. market.

Semaglutide is the active ingredient in Ozempic and Wegovy. It’s a synthetic form of GLP-1, a hormone that regulates our ...

Novo Nordisk stock experienced a sharp decline after disappointing 2025 results and 2026 outlook but has seen a bounce back since. Click to read my NVO update.

Pharmaceutical giant Novo Nordisk announced Monday it is suing telemedicine platform Hims & Hers for allegedly “deceiving patients and putting their health at risk” by selling compounded versions of ...

Novo Nordisk vowed to take legal action against telehealth company Hims & Hers for selling a knockoff of its weight loss pill ...

By Andrew Silver SHANGHAI, Feb 5 (Reuters) - Sales of Novo Nordisk's blockbuster diabetes drug Ozempic in the greater China ...

Semaglutide is the active ingredient in Wegovy® and Ozempic® and, unlike any other molecule in the GLP-1 class, has FDA-approved medicines with indications for patients with obesity (Wegovy®), type 2 ...

Novo Nordisk brought in Justin Long and John Hodgman, who had been in the Apple "Get A Mac" ads from 20 years ago, to star in ...